Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer
2021 · Journal of Experimental & Clinical Cancer Research · 502 citations
https://doi.org/10.1186/s13046-021-01987-7
W
Wantao Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
3.5K
Citations
21
h-index
35
i10-index
Wantao Wu is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Immune cells in cancer & Cancer Immunotherapy and Biomarkers & Ferroptosis and cancer prognosis. The author has an h-index of 21, co-authored 46 publications.
Papers by this author
worksDefine cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
2023 · Molecular Cancer · 341 citations
https://doi.org/10.1186/s12943-023-01860-5
Immune checkpoint modulators in cancer immunotherapy: recent advances and emerging concepts
2022 · Journal of Hematology & Oncology · 257 citations
https://doi.org/10.1186/s13045-022-01325-0
The molecular feature of macrophages in tumor immune microenvironment of glioma patients
2021 · Computational and Structural Biotechnology Journal · 142 citations
https://doi.org/10.1016/j.csbj.2021.08.019
B2M overexpression correlates with malignancy and immune signatures in human gliomas
2021 · Scientific Reports · 77 citations
https://doi.org/10.1038/s41598-021-84465-6
Molecular insight into pentraxin-3: Update advances in innate immunity, inflammation, tissue remodeling, diseases, and drug role
2022 · Biomedicine & Pharmacotherapy · 44 citations
https://doi.org/10.1016/j.biopha.2022.113783
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat